- Home
- CBUS vs FBRX Comparison
CBUS vs FBRX Comparison
Compare CBUS & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBUS
- FBRX
- Stock Information
- Founded
- CBUS 2010
- FBRX N/A
- Country
- CBUS United States
- FBRX United States
- Employees
- CBUS N/A
- FBRX N/A
- Industry
- CBUS Agricultural Chemicals
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- CBUS Industrials
- FBRX Health Care
- Exchange
- CBUS Nasdaq
- FBRX Nasdaq
- Market Cap
- CBUS 65.3M
- FBRX 69.7M
- IPO Year
- CBUS 2017
- FBRX N/A
- Fundamental
- Price
- CBUS $1.55
- FBRX $13.66
- Analyst Decision
- CBUS Strong Buy
- FBRX Strong Buy
- Analyst Count
- CBUS 3
- FBRX 2
- Target Price
- CBUS $22.00
- FBRX $61.00
- AVG Volume (30 Days)
- CBUS 927.1K
- FBRX 178.3K
- Earning Date
- CBUS 08-07-2025
- FBRX 08-13-2025
- Dividend Yield
- CBUS N/A
- FBRX N/A
- EPS Growth
- CBUS N/A
- FBRX N/A
- EPS
- CBUS N/A
- FBRX N/A
- Revenue
- CBUS $4,751,000.00
- FBRX N/A
- Revenue This Year
- CBUS $32.97
- FBRX N/A
- Revenue Next Year
- CBUS $66.40
- FBRX N/A
- P/E Ratio
- CBUS N/A
- FBRX N/A
- Revenue Growth
- CBUS 104.78
- FBRX N/A
- 52 Week Low
- CBUS $1.38
- FBRX $4.11
- 52 Week High
- CBUS $10.77
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- CBUS 42.57
- FBRX 59.38
- Support Level
- CBUS $1.40
- FBRX $10.15
- Resistance Level
- CBUS $1.67
- FBRX $19.63
- Average True Range (ATR)
- CBUS 0.14
- FBRX 2.05
- MACD
- CBUS 0.02
- FBRX -0.06
- Stochastic Oscillator
- CBUS 62.07
- FBRX 39.85
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).